摘要
巨细胞病毒 (Cytomegalovirus ,CMV)感染是肾移植受者重要的患病和死亡原因。本文综述了近年来巨细胞病毒感染的研究进展。结合CMV的分子生物学特点阐述了其免疫逃避、大量复制以及引发疾病的机制。
出处
《国外医学（泌尿系统分册）》
2004年第4期496-499,共4页
Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
参考文献17
-
1Bankier AT,Beck S,Bohni R,et al.The DNA sequence of the human cytomegalovirus genome.DNA Seq,1991,2(1),1～12
-
2Cha TA,Tom E,Kemble GW,et al.Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.J Virol,1996,70(1),78～83
-
3Prichard MN,Penfold ME,Duke GM,et al.A review of genetic differences between limited and extensively passaged human cytomegalovirus strains.Rev Med Virol,2001,11(3),191～200
-
4Rehm A,Engelsberg A,Tortorella D,et al.Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells.J Virol,2002,76(10),5043～50
-
5Braud VM,Tomasec P,Wilkinson GW.Viral evasion of natural killer cells during human cytomegalovirus infection.Curr Top Microbiol Immunol,2002,269,117～129
-
6Kotenko SV,Saccani S,Izotova LS,et al.Human cytomegalovirus harbors its own unique IL-10 homolog(cmvIL-10).Proc Natl Acad Sci USA,2000,97(4),1695～700
-
7Emery VC,Cope AV,Bowen Ef,et al.The dynamics of human cytomegalovirus replication in vivo.J Exp Med,1999,190(2),177～82
-
8Prosch S,Wuttke R,Kruger DH,et al.NF-kappaB-a potential therapeutic target for inhibition of human cytomegalovirus(re)activation? Biol Chem,2002,383(10),1601～9
-
9Burns LJ,Pooley JC,Walsh DJ,et al.Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins.Transplantation,1999,67(1),137～44
-
10Yurochko AD,Hwang ES,Rasmussen L,et al.The human cytomegalovirus UL55(gB) and UL75(gH) glycoprotein ligands initiate the rapid activation of Sp1 andNF-kappaB during infection.J Virol,1997,71(7),5051～9
同被引文献9
-
1Muller GA,Muller CA,Einsele H,et al.Cytomegalovirus infection:how to manage it in the immunocompromised transplant recipient.Nephrol Dial Transplant,1994,9:3
-
2Konoplev S,Champlin RE,Giralt S,et al.Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients.Bone Marrow,Transplant,2001,27:877
-
3Storch GA.Viral infections in immunocompromised patients.Clinical Infectious Diseases,2000,31:739
-
4Franquet T,Lee KS,Müller NL,et al.Thin-section CT findings in 32 immunocompromised patients with cytomegalovirus pneumonia who do not have AIDS.AJR,2003,181:1059
-
5Moon JH,Kim EA,Lee KS,et al.Cytomegalovirus pneumonia:high-resolution CT findings in ten non-AIDS immunocompromised patients.Korean J Radiol,2000,1:73
-
6章咏裳.肾移植术后巨细胞病毒感染[J].中华器官移植杂志,2000,21(4):248-249. 被引量：49
-
7洪良庆,郑克立,高新.肾移植术后巨细胞病毒感染的诊治(附42例报告)[J].中华泌尿外科杂志,2000,21(7):412-414. 被引量：7
-
8许元文,朱兰英,吴培根,毛海萍,梁艳冰,纪玉莲,沈清瑞,郑克立,洪良庆.巨细胞病毒-PP65抗原监测在预防肾移植术后巨细胞病毒病中的应用[J].中华肾脏病杂志,2000,16(4):248-250. 被引量：13
-
9赵缜.人巨细胞病毒pp65疫苗的研究进展[J].国外医学（流行病学．传染病学分册）,2002,29(2):92-94. 被引量：8
二级引证文献7
-
1彭振丽,卢冰冰,高占成,曲星珂,曹照龙,董霄松,王晓峰.29例肾移植受者肺炎临床特点研究分析[J].中国呼吸与危重监护杂志,2008,7(1):20-25. 被引量：10
-
2盛翠云,韩铭钧,关文华,秦培鑫,刘小彬.造血干细胞移植术后肺部非感染性并发症的CT分析[J].放射学实践,2008,23(7):759-761. 被引量：1
-
3周浩,王毅,王芳,秦国庆.肾移植术后巨细胞病毒感染的诊治进展[J].现代生物医学进展,2009,9(2):391-394. 被引量：6
-
4陈晓荣,王宏宇,夏进东,张珊珊,徐松,张旭辉.肾移植患者术后巨细胞病毒肺炎的CT表现[J].中国基层医药,2010,17(20):2785-2786. 被引量：1
-
5范振磊,马超龙.肾移植术后肺部感染的诊治[J].国际移植与血液净化杂志,2011,9(1):1-5.
-
6乔虹,王东信,李双玲,张捷.外科重症监护病房肾移植术后严重肺部感染患者的处理[J].肾脏病与透析肾移植杂志,2011,20(5):408-411. 被引量：3
-
7索有军,徐洪山,龚理.器官移植后的监护处理[J].中国组织工程研究,2013,17(44):7797-7802.
-
1胥广,黄东.增生性瘢痕形成机制及治疗的现况与展望[J].现代医院,2015,15(2):10-14. 被引量：9
-
2高陈,彭龙开.肾移植术后巨细胞病毒感染的诊断和防治进展[J].复旦学报（医学版）,2011,38(2):172-177. 被引量：6
-
3肖培,徐正红,芦幸,杨红枚.肾移植术后巨细胞病毒感染的研究进展[J].临床泌尿外科杂志,2012,27(10):796-800. 被引量：4
-
4陈军.入夏需防哪些病[J].养生大世界（B版）,2007(6):35-35.
-
5韩聪祥,于立新.肾移植受者巨细胞病毒感染的诊治[J].广东医学,2005,26(4):446-448. 被引量：2
-
6眭元庚.前列腺的组织结构、功能与疾病的关系[J].实用老年医学,2005,19(4):171-173.
-
7尹广.器官移植患者巨细胞病毒感染的诊断、预防及治疗[J].传染病信息,2001,14(2):65-68. 被引量：2
-
8兰平,张梅.肿瘤免疫逃避新机制—肿瘤细胞FasL表达(文献综述)[J].国际外科学杂志,1997,28(6):336-337. 被引量：4
-
9吴培根.肾移植受者巨细胞病毒感染的早期快速诊断与防治[J].新医学,2003,34(1):50-51. 被引量：2
-
10童静.冬季虽寒冷 开窗不能省[J].保健医苑,2008(11):52-52.
